Alivus Life Sciences Limited (NSE:ALIVUS)
India · Delayed Price · Currency is INR 1,380.00
+0.70 (0.05%)
Oct 1, 2026, 3:30 PM IST
Alivus Life Sciences Market Cap
Alivus Life Sciences has a market cap or net worth of 168.67 billion as of October 1, 2026. Its market cap has increased by 47.97% in one year.
Market Cap
168.67B
Enterprise Value
161.41B
Revenue
25.90B
Ranking
n/a
PE Ratio
28.03
Stock Price
1,380.00
ChartMarket Cap Chart
Since August 6, 2021, Alivus Life Sciences's market cap has increased from 91.71B to 168.67B, an increase of 83.91%. That is a compound annual growth rate of 12.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 168.67B | 49.99% |
| Dec 31, 2025 | 112.45B | -6.68% |
| Dec 31, 2024 | 120.50B | 49.68% |
| Dec 29, 2023 | 80.51B | 56.38% |
| Dec 30, 2022 | 51.48B | -33.42% |
| Dec 31, 2021 | 77.32B | -15.69% |
| Aug 6, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 371.60B |
| Wockhardt | 355.47B |
| Piramal Pharma | 274.61B |
| Cohance Lifesciences | 173.42B |
| Eris Lifesciences | 169.16B |
| Alembic Pharmaceuticals | 167.93B |
| NATCO Pharma | 148.40B |
| Sudeep Pharma | 128.63B |